Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDITION JP I: Toujeo vs Lantus in Japanese T1DM
NCT01689129Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2012
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Sep 2012; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01689129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689129.